The authors present a risk analysis of the impact of various business and operating risks on three facility layout strategies.
Mark Witcher
Advertisement
Mark Witcher is a consultant, witchermf@aol.com
Articles by Mark Witcher
FDA’s 21st Century goals can be realized by using a multi-purpose manufacturing facility with a flexible design that provides reliable production without extensive regulatory oversight.
Advertisement
Latest Updated Articles
- How FDA’s 21st Century Goals Can Be Realized by Using a Multi-Purpose Manufacturing Facility
Published: November 29th 2018 | Updated:
Comparing Facility Layout Options for Managing Business and Operating RisksPublished: June 1st 2019 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
